ASSAYS FOR FIBRINOGEN-FIBRIN DEGRADATION PRODUCTS IN BIOLOGICAL FLUIDS: SOME METHODOLOGICAL ASPECTS.DONATI MB.1975; THROMBOSIS DIATHESIS HAEMORRHAG.; ALLEM.; DA. 1975; VOL. 34; NO 3; PP. 652-660; BIBL. 3 P.Article

EVIDENCE THAT BOVINE FACTOR VIII, NOT BOVINE FIBRINOGEN, AGGREGATES HUMAN PLATELETS = PREUVE QUE LE FACTEUR VIII ET NON LE FIBRINOGENE DES BOVINS AGREGE LES PLAQUETTES HUMAINESDONATI MB; DE GAETANO G; VERMYLEN J et al.1973; THROMBOSIS RES.; G.B.; DA. 1973; VOL. 2; NO 1; PP. 97-104; BIBL. 1 P. 1/2Serial Issue

THE EFFECTS OF DRUGS ON PLATELET FUNCTION TESTS.DE GAETANO G; DONATI MB; GARATTINI S et al.1976; THROMBOSIS AND HAEMOSTASIS; GERM.; DA. 1976; VOL. 36; NO 1; PP. 281; BIBL. 3 REF.Article

CALIBRACION DE COLUMNAS DE AGAROSA PARA EL ESTUDIO DEL FIBRINOGENO HUMANO Y SUS DERIVADOS = CALIBRAGE DES COLONNES D'AGAROSE POUR L'ETUDE DU FIBRINOGENE HUMAIN ET DE SES DERIVESCULASSO D; DONATI MB; VERMYLEN J et al.1975; REV. AS. BIOQUIM. ARGENT.; ARGENT.; DA. 1975; VOL. 40; NO 220; PP. 39-45; BIBL. 9REFArticle

BLEEDING TIME IN LABORATORY ANIMALS. I. ASPIRIN DOES NOT PROLONG BLEEDING TIME IN RATSSTELLA L; DONATI MB; DE GAETANO G et al.1975; THROMBOSIS RES.; G.B.; DA. 1975; VOL. 7; NO 5; PP. 709-716; BIBL. 1 P. 1/2Article

THE ANTIGENIC DETERMINANT OF FIBRIN (OGEN) MEASURED WITH AGGLUTINATION INHIBITION IMMUNOASSAYSMOLLA A; DONATI MB; VERMYLEN J et al.1974; J. CLIN. PATHOL.; G.B.; DA. 1974; VOL. 27; NO 6; PP. 473-479; BIBL. 26REF.Serial Issue

HEPARIN COUNTERACTS THE ANTIAGGREGATING EFFECT OF PROSTACYCLIN BY POTENTIATING PLATELET AGGREGATIONBERTELE V; RONCAGLIONI MC; DONATI MB et al.1983; THROMBOSIS AND HAEMOSTASIS; ISSN 0340-6245; DEU; DA. 1983; VOL. 49; NO 2; PP. 81-83; BIBL. 7 REF.Article

FIBRIN CLOT RETRACTILE (FCR) ACTIVITY OF FIBROBLAST-LIKE CELLS FROM NORMAL INDIVIDUALS AND CANCER PATIENTS = ACTIVITE SUR LA RETRACTION DU CAILLOT DE FIBRINE DES CELLULES FIBROBLASTOIDES OBTENUES A PARTIR D'INDIVIDUS NORMAUX OU DE PATIENTS CANCEREUXCURATOLO L; BORGIA R; DONATI MB et al.1982; CELL BIOL. INT. REP.; ISSN 0309-1651; GBR; DA. 1982; VOL. 6; NO 6; PP. 609-618; BIBL. 2 P.Article

FAILURE OF ASPIRIN AT DIFFERENT DOSES TO MODIFY EXPERIMENTAL THROMBOSIS IN RATSREYERS I; MUSSONI L; DONATI MB et al.1980; THROMBOSIS RES.; GBR; DA. 1980; VOL. 18; NO 5; PP. 669-674; BIBL. 12 REF.Article

REDUCED PROCOAGULANT ACTIVITY OF LEWIS LUNG CARCINOMA CELLS FROM MICE TREATED WITH WARFARINPOGGI A; COLUCCI M; DELAINI F et al.1980; EUR. J. CANCER; ISSN 0014-2964; GBR; DA. 1980; VOL. 16; NO 12; PP. 1641-1642; BIBL. 9 REF.Article

BLOOD COAGULATION CHANGES IN JW SARCOMA, A NEW METASTASIZING TUMOUR IN MICECHMIELEWSKA J; POGGI A; MUSSONI L et al.1980; EUR. J. CANCER; ISSN 0014-2964; GBR; DA. 1980; VOL. 16; NO 11; PP. 1399-1407; BIBL. 39 REF.Article

PLASMINOGEN ASSAY IN RABBIT, RAT AND MOUSE PLASMA USING THE CHROMOGENIC SUBSTRATE S-2251MUSSONI L; RACZKA E; CHMIELEWSKA J et al.1979; THROMBOSIS RES.; GBR; DA. 1979; VOL. 15; NO 3-4; PP. 341-349; BIBL. 11 REF.Article

DITAZOLE AND PLATELETS. III. EFFECT OF DITAZOLE AND TUMOR-CELL INDUCED THROMBOCYTOPENIA AND ON BLEEDING TIME IN MICE.MUSSONI L; POGGI A; DONATI MB et al.1977; HAEMOSTASIS; SWITZ.; DA. 1977; VOL. 6; NO 4; PP. 260-265; BIBL. 14 REF.Article

IMPAIRED SPREADING OF TRANSFORMED CELLS ON FIBRIN SUBSTRATE = PERTURBATION DE L'ETALEMENT DES CELLULES TRANSFORMEES SUR UN SUBSTRAT DE FIBRINEDONATI MB; CURATOLO L; AMATO G et al.1983; CELL BIOLOGY INTERNATIONAL REPORTS; ISSN 0309-1651; GBR; DA. 1983; VOL. 7; NO 6; PP. 427-432; BIBL. 16 REF.Article

OCCURRENCE OF DISSEMINATED INTRAVASCULAR COAGULATION IN RAT BNML LEUKAEMIA DESPITE LACK OF LEUCOCYTE PROCOAGULANT ACTIVITYCOLUCCI M; LORENZET R; LOCATI D et al.1983; BRITISH JOURNAL OF EXPERIMENTAL PATHOLOGY; ISSN 0007-1021; GBR; DA. 1983; VOL. 64; NO 2; PP. 207-210; BIBL. 13 REF.Article

FIBRIN CLOT RETRACTILE ACTIVITY OF MOUSE FIBROBLASTS DURING GROWTH AND AGINGCURATOLO L; BALCONI G; BORGIA R et al.1980; IN VITRO; ISSN 0073-5655; USA; DA. 1980; VOL. 16; NO 9; PP. 731-737; BIBL. 20 REF.Article

INCREASED PGI₂ ACTIVITY IN VENOUS TISSUES FROM RATS AN ORAL CONTRACEPTIVES IS NOT PREVENTED BY HEPARIN ADMINISTRATION BEFORE VESSEL ISOLATIONRONCAGLIONI MC; DIMINNO G; GAETANO G et al.1980; THROMB. RES.; ISSN 0049-3848; USA; DA. 1980; VOL. 18; NO 6; PP. 895-896; BIBL. 3 REF.Article

EARLY INCREASE OF A NEW PLATELET COAGULANT ACTIVITY IN RATS FED A THROMBOGENIC DIETTREMOLI E; COLUCCI M; DONATI MB et al.1979; ATHEROSCLEROSIS; NLD; DA. 1979; VOL. 33; NO 2; PP. 239-244; BIBL. 23 REF.Article

BIOLOGICAL PROPERTIES OF DIALYSABLE PEPTIDES DERIVED FROM PLASMIN DIGESTION OF BOVINE FIBRINOGEN PREPARATIONS.BUCZKO W; DE GAETANO G; FRANCO R et al.1976; THROMBOSIS AND HAEMOSTASIS; GERM.; DA. 1976; VOL. 35; NO 2; PP. 651-657; ABS. FR. ALLEM.; BIBL. 13 REF.Article

RAT BLOOD LEUCOCYTES, UNLIKE RABBIT LEUCOCYTES, DO NOT GENERATE PROCOAGULANT ACTIVITY ON EXPOSURE TO ENDOTOXINSEMERARO N; COLUCCI M; MUSSONI L et al.1981; BR. J. EXP. PATHOL.; ISSN 0007-1021; GBR; DA. 1981; VOL. 62; NO 6; PP. 638-642; BIBL. 25 REF.Article

CANCER CELL PROCOAGULANT ACTIVITY: EVALUATION BY AN AMIDOLYTIC ASSAYCOLUCCI M; CURATOLO L; DONATI MB et al.1980; THROMBOSIS RES.; GBR; DA. 1980; VOL. 18; NO 3-4; PP. 589-595; BIBL. 13 REF.Article

RENI ED EMOSTASI. I: SIGNIFICATO DELLA PRESENZA DI MATERIALE FIBRINOGENO SIMILE NELLE MALATTIE RENALI IMMUNOLOGICHE E NELLE CRISI DI RIGETTO DEI TRAPIANTI RENALI = REINS ET HEMOSTASE. I. SIGNIFICATION DE LA PRESENCE DE SUBSTANCE SEMBLABLE AU FIBRINOGENE DANS LES MALADIES RENALES IMMUNOLOGIQUES ET DANS LES CRISES DE REJET APRES TRANSPLANTATION DE REINDONATI MB; DE GAETANO G; VERMYLEN J et al.1972; CLIN. TERAPEUT.; ITAL.; DA. 1972; VOL. 63; NO 5; PP. 407-423; BIBL. 1 P. 1/2Serial Issue

INHIBITION OF HUMAN PLATELET AGGREGATION BY PLASMIN DIGESTS OF HUMAN AND BOVINE FIBRINOGEN PREPARATIONS: ROLE OF CONTAMINATING FACTOR VIII-RELATED MATERIAL = INHIBITION DE L'AGREGATION DES PLAQUETTES HUMAINES PAR LES PRODUITS DE DIGESTION PAR LA PLASMINE DES FIBRINOGENES HUMAIN ET BOVIN: CONTAMINATION PAR LE MATERIEL LIE AU FACTEUR VIIICULASSO DE; DONATI MB; DE GAETANO G et al.1974; BLOOD; U.S.A.; DA. 1974; VOL. 44; NO 2; PP. 169-175; BIBL. 23REF.Article

RENI ED EMOSTASI. II. APPROCCIO TERAPEUTICO DI ALCUNE MALATTIE RENALI IMMUNOLOGICHE CON FARMACICHE INIBISCONO L'AGGREGAZIONE PIASTRINICA = REIN ET HEMOSTASE. II. APPROCHE THERAPEUTIQUE DE QUELQUES MALADIES RENALES IMMUNOLOGIQUES A L'AIDE DE MEDICAMENTS QUI INHIBENT L'AGREGATION PLAQUETTAIREDE GAETANO G; DONATI MB; VERMYLEN J et al.1972; CLIN. TERAPEUT.; ITAL.; DA. 1972; VOL. 63; NO 5; PP. 425-435; BIBL. 1P.Serial Issue

HUMAN BLOOD LEUCOCYTES IN VITRO GENERATE AN INHIBITOR OF PLATELET AGGREGATIONVILLA S; ROTILIO D; DONATI MB et al.1981; THROMB. RES.; ISSN 0049-3848; USA; DA. 1981; VOL. 24; NO 5-6; PP. 485-487; BIBL. 11 REF.Article